pentobarbital will lessen the extent or result of temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will lessen the level or effect of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.
pentobarbital will minimize the level or result of etravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will reduce the level or impact of paclitaxel protein bound by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unknown.
To attenuate the possibility of overdosage or the event of dependence, Restrict the prescribing and dispensing of sedative-hypnotic barbiturates, to the quantity expected for that interval until finally the next appointment
Barbiturates are pregnancy group D medicine and are demonstrated to induce fetal damage if Employed in Expecting individuals. This course of medicines can cross the placental barrier and distribute through the fetal tissue with the highest concentrations from the liver, Mind, and placenta.
fentanyl transdermal and pentobarbital each raise sedation. Avoid or Use Alternate Drug. Restrict use to patients for whom choice therapy solutions are inadequate
pentobarbital will lessen the level or effect of ambrisentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Not known.
pentobarbital increases toxicity of buprenorphine, extensive-performing injection by pharmacodynamic synergism. Modify Therapy/Check Closely. Coadministration of buprenorphine and benzodiazepines or other CNS depressants improves chance of adverse reactions such as overdose, respiratory depression, and Dying. Cessation of benzodiazepines or other CNS depressants is desired usually.
pentobarbital will lower the extent or influence of sufentanil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.
pentobarbital will lower the extent or influence of vincristine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.
pentobarbital will reduce the extent or impact of nilotinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
Using barbiturates as sedatives in the postoperative surgical period of time and as adjuncts to most cancers chemotherapy is well set up
pentobarbital will decrease the extent or click here impact of itraconazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar.